Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
16805 | 635 | 37.0 | 54% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
537 | 3 | BIOARTIFICIAL LIVER//HEPATOCYTES//HEPATOCYTE TRANSPLANTATION | 19236 |
908 | 2 | BIOARTIFICIAL LIVER//HEPATOCYTES//HEPATOCYTE TRANSPLANTATION | 11255 |
16805 | 1 | PHOSPHOLIPIDOSIS//CATIONIC AMPHIPHILIC DRUGS//DRUG INDUCED PHOSPHOLIPIDOSIS | 635 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PHOSPHOLIPIDOSIS | authKW | 2317840 | 12% | 63% | 77 |
2 | CATIONIC AMPHIPHILIC DRUGS | authKW | 876710 | 4% | 65% | 28 |
3 | DRUG INDUCED PHOSPHOLIPIDOSIS | authKW | 769375 | 3% | 100% | 16 |
4 | DICATIONIC AMPHIPHILIC DRUGS | authKW | 240430 | 1% | 100% | 5 |
5 | TILORONE | authKW | 176300 | 2% | 33% | 11 |
6 | LYSOSOMAL TRAPPING | authKW | 171733 | 1% | 71% | 5 |
7 | BISMONOACYLGLYCEROPHOSPHATE | authKW | 170963 | 1% | 44% | 8 |
8 | GLYCOSAMINOGLYCANS SULFATED | authKW | 144258 | 0% | 100% | 3 |
9 | LIPIDTOX | authKW | 144258 | 0% | 100% | 3 |
10 | DRUG INDUCED STEATOHEPATITIS | authKW | 108192 | 0% | 75% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Toxicology | 4636 | 26% | 0% | 164 |
2 | Pharmacology & Pharmacy | 1641 | 31% | 0% | 196 |
3 | Biochemistry & Molecular Biology | 592 | 28% | 0% | 179 |
4 | Pathology | 519 | 9% | 0% | 55 |
5 | Biophysics | 349 | 9% | 0% | 60 |
6 | Chemistry, Medicinal | 134 | 5% | 0% | 32 |
7 | Biochemical Research Methods | 62 | 4% | 0% | 27 |
8 | Cell Biology | 57 | 7% | 0% | 44 |
9 | Medicine, Research & Experimental | 38 | 4% | 0% | 26 |
10 | Chemistry, Analytical | 16 | 4% | 0% | 24 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PS ADM | 96172 | 0% | 100% | 2 |
2 | BIOTECHNOL BIOENGN UNIT | 64113 | 0% | 67% | 2 |
3 | A 110 | 48086 | 0% | 100% | 1 |
4 | ANALYT SCI STEVENAGE | 48086 | 0% | 100% | 1 |
5 | BIO MOL S | 48086 | 0% | 100% | 1 |
6 | CELLECTIS AB CELLARTIS AB | 48086 | 0% | 100% | 1 |
7 | CIBEREHDFIS | 48086 | 0% | 100% | 1 |
8 | CLIN SAFETY LICENSING EARLY DEV | 48086 | 0% | 100% | 1 |
9 | CLUSTER BIOASSAYS TOXICOL | 48086 | 0% | 100% | 1 |
10 | DIS DEV WORLD DDW | 48086 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE | 6006 | 2% | 1% | 10 |
2 | TOXICOLOGY IN VITRO | 5355 | 3% | 1% | 22 |
3 | TOXICOLOGY AND APPLIED PHARMACOLOGY | 3808 | 4% | 0% | 28 |
4 | TOXICOLOGIC PATHOLOGY | 2706 | 2% | 0% | 12 |
5 | EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY | 2106 | 1% | 0% | 9 |
6 | BIOCHEMICAL PHARMACOLOGY | 1725 | 4% | 0% | 26 |
7 | EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | 1379 | 1% | 0% | 6 |
8 | TOXICOLOGY | 1331 | 2% | 0% | 14 |
9 | BIOCHIMICA ET BIOPHYSICA ACTA | 1276 | 4% | 0% | 28 |
10 | JOURNAL OF LIPID RESEARCH | 1248 | 2% | 0% | 15 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PHOSPHOLIPIDOSIS | 2317840 | 12% | 63% | 77 | Search PHOSPHOLIPIDOSIS | Search PHOSPHOLIPIDOSIS |
2 | CATIONIC AMPHIPHILIC DRUGS | 876710 | 4% | 65% | 28 | Search CATIONIC+AMPHIPHILIC+DRUGS | Search CATIONIC+AMPHIPHILIC+DRUGS |
3 | DRUG INDUCED PHOSPHOLIPIDOSIS | 769375 | 3% | 100% | 16 | Search DRUG+INDUCED+PHOSPHOLIPIDOSIS | Search DRUG+INDUCED+PHOSPHOLIPIDOSIS |
4 | DICATIONIC AMPHIPHILIC DRUGS | 240430 | 1% | 100% | 5 | Search DICATIONIC+AMPHIPHILIC+DRUGS | Search DICATIONIC+AMPHIPHILIC+DRUGS |
5 | TILORONE | 176300 | 2% | 33% | 11 | Search TILORONE | Search TILORONE |
6 | LYSOSOMAL TRAPPING | 171733 | 1% | 71% | 5 | Search LYSOSOMAL+TRAPPING | Search LYSOSOMAL+TRAPPING |
7 | BISMONOACYLGLYCEROPHOSPHATE | 170963 | 1% | 44% | 8 | Search BISMONOACYLGLYCEROPHOSPHATE | Search BISMONOACYLGLYCEROPHOSPHATE |
8 | GLYCOSAMINOGLYCANS SULFATED | 144258 | 0% | 100% | 3 | Search GLYCOSAMINOGLYCANS+SULFATED | Search GLYCOSAMINOGLYCANS+SULFATED |
9 | LIPIDTOX | 144258 | 0% | 100% | 3 | Search LIPIDTOX | Search LIPIDTOX |
10 | DRUG INDUCED STEATOHEPATITIS | 108192 | 0% | 75% | 3 | Search DRUG+INDUCED+STEATOHEPATITIS | Search DRUG+INDUCED+STEATOHEPATITIS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SHAYMAN, JA , ABE, A , (2013) DRUG INDUCED PHOSPHOLIPIDOSIS: AN ACQUIRED LYSOSOMAL STORAGE DISORDER.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. VOL. 1831. ISSUE 3. P. 602-611 | 42 | 64% | 19 |
2 | PRZYBYLAK, KR , ALZAHRANI, AR , CRONIN, MTD , (2014) HOW DOES THE QUALITY OF PHOSPHOLIPIDOSIS DATA INFLUENCE THE PREDICTIVITY OF STRUCTURAL ALERTS?.JOURNAL OF CHEMICAL INFORMATION AND MODELING. VOL. 54. ISSUE 8. P. 2224 -2232 | 34 | 79% | 2 |
3 | MUEHLBACHER, M , TRIPAL, P , ROAS, F , KORNHUBER, J , (2012) IDENTIFICATION OF DRUGS INDUCING PHOSPHOLIPIDOSIS BY NOVEL IN VITRO DATA.CHEMMEDCHEM. VOL. 7. ISSUE 11. P. 1925 -1934 | 49 | 56% | 6 |
4 | VAN DE WATER, FM , HAVINGA, J , RAVESLOOT, WT , HORBACH, GJMJ , SCHOONEN, WGEJ , (2011) HIGH CONTENT SCREENING ANALYSIS OF PHOSPHOLIPIDOSIS: VALIDATION OF A 96-WELL ASSAY WITH CHO-K1 AND HEPG2 CELLS FOR THE PREDICTION OF IN VIVO BASED PHOSPHOLIPIDOSIS.TOXICOLOGY IN VITRO. VOL. 25. ISSUE 8. P. 1870-1882 | 41 | 61% | 14 |
5 | GORACCI, L , BURATTA, S , URBANELLI, L , FERRARA, G , DI GUIDA, R , EMILIANI, C , CROSS, S , (2015) EVALUATING THE RISK OF PHOSPHOLIPIDOSIS USING A NEW MULTIDISCIPLINARY PIPELINE APPROACH.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. VOL. 92. ISSUE . P. 49 -63 | 30 | 70% | 8 |
6 | MONTEITH, DK , MORGAN, RE , HALSTEAD, B , (2006) IN VITRO ASSAYS AND BIOMARKERS FOR DRUG-INDUCED PHOSPHOLIPIDOSIS.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 2. ISSUE 5. P. 687-696 | 33 | 75% | 27 |
7 | NONOYAMA, T , FUKUDA, R , (2008) DRUG-INDUCED PHOSPHOLIPIDOSIS-PATHOLOGICAL ASPECTS AND ITS PREDICTION.JOURNAL OF TOXICOLOGIC PATHOLOGY. VOL. 21. ISSUE 1. P. 9 -24 | 40 | 56% | 39 |
8 | REASOR, MJ , HASTINGS, KL , ULRICH, RG , (2006) DRUG-INDUCED PHOSPHOLIPIDOSIS: ISSUES AND FUTURE DIRECTIONS.EXPERT OPINION ON DRUG SAFETY. VOL. 5. ISSUE 4. P. 567-583 | 42 | 46% | 115 |
9 | RUBEN, Z , RORIG, KJ , KACEW, S , (1993) PERSPECTIVES ON INTRACELLULAR STORAGE AND TRANSPORT OF CATIONIC-LIPOPHILIC DRUGS.PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE. VOL. 203. ISSUE 2. P. 140-149 | 49 | 72% | 6 |
10 | TAKAGI, M , SANOH, S , SANTOH, M , EJIRI, Y , KOTAKE, Y , OHTA, S , (2016) DETECTION OF METABOLIC ACTIVATION LEADING TO DRUG-INDUCED PHOSPHOLIPIDOSIS IN RAT HEPATOCYTE SPHEROIDS.JOURNAL OF TOXICOLOGICAL SCIENCES. VOL. 41. ISSUE 1. P. 155 -164 | 23 | 77% | 0 |
Classes with closest relation at Level 1 |